These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9403859)

  • 1. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor.
    Trullas R
    Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():55-6. PubMed ID: 9403859
    [No Abstract]   [Full Text] [Related]  

  • 2. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P; Franks NP; Dickinson R
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dantrolene antagonizes the glycineB site of the NMDA receptor.
    Salinska E; Sobczuk A; Lazarewicz JW
    Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
    Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds.
    Schmieden V; Jezequel S; Betz H
    Mol Pharmacol; 1996 Nov; 50(5):1200-6. PubMed ID: 8913351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition.
    Mott DD; Doherty JJ; Zhang S; Washburn MS; Fendley MJ; Lyuboslavsky P; Traynelis SF; Dingledine R
    Nat Neurosci; 1998 Dec; 1(8):659-67. PubMed ID: 10196581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK-315716/UK-240455. Pfizer.
    Capelli AM; Micheli F
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1737-9. PubMed ID: 11892937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern aspects of investigation and clinical application of glutamatergic agents].
    Petrov VI; Onishchenko NV
    Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM; Solís JM
    Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
    J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.